Glenview Capital Management 13F, Q2 2024
Larry Robbins · quarter ending 30 June 2024 · filed 14 August 2024 · SEC CIK 1138995
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 2 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q2 2024
The 25 largest of 46 positions. Weights are against the whole filed book. Changes are in shares held, against the Q1 2024 filing.
| Company | Ticker | Value | % of book | vs Q1 2024 |
|---|---|---|---|---|
| TENET HEALTHCARE CORP | THC | $620.68M | 13.2% | -26% shares |
| CVS HEALTH CORP | CVS | $541.13M | 11.5% | +440% shares |
| THE CIGNA GROUP | CI | $427.69M | 9.1% | -12% shares |
| GLOBAL PMTS INC | GPN | $301.54M | 6.4% | +31% shares |
| CORTEVA INC | CTVA | $273.61M | 5.8% | -25% shares |
| ALIGHT INC | ALITEUR | $227.72M | 4.8% | +9% shares |
| UNIVERSAL HLTH SVCS INC | UHS | $219.01M | 4.6% | -42% shares |
| ELEMENT SOLUTIONS INC | ESI | $171.59M | 3.6% | -24% shares |
| DXC TECHNOLOGY CO | DXC | $166.21M | 3.5% | -32% shares |
| MCKESSON CORP | MCK | $155.19M | 3.3% | -8% shares |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $148.81M | 3.1% | +22% shares |
| CLARIVATE PLC | $145.96M | 3.1% | +4% shares | |
| US FOODS HLDG CORP | USFD | $132.18M | 2.8% | unchanged |
| CENTENE CORP DEL | CNC | $94.90M | 2.0% | new |
| MYRIAD GENETICS INC | MYGN | $91.69M | 1.9% | -24% shares |
| UBER TECHNOLOGIES INC | UBER | $87.01M | 1.8% | +6% shares |
| EXPEDIA GROUP INC | EXPE | $75.52M | 1.6% | -2% shares |
| KNIGHT-SWIFT TRANSN HLDGS IN | KNX | $72.62M | 1.5% | +10% shares |
| VIATRIS INC | VTRS | $69.04M | 1.5% | +26% shares |
| AMAZON COM INC | AMZN | $67.72M | 1.4% | -13% shares |
| HCA HEALTHCARE INC | HCA | $62.84M | 1.3% | unchanged |
| WESCO INTL INC | WCC | $60.52M | 1.3% | new |
| MARVELL TECHNOLOGY INC | MRVL | $60.30M | 1.3% | -37% shares |
| AVIS BUDGET GROUP | CAR | $55.38M | 1.2% | +193% shares |
| ELEVANCE HEALTH INC | ELV | $53.42M | 1.1% | -43% shares |
What changed since Q1 2024
Against the Q1 2024 filing, Glenview Capital Management opened 9 new positions, added to 13, trimmed 17, left 7 unchanged and exited 6. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000905148-24-002216, filed by GLENVIEW CAPITAL MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.